NASDAQ Companies

―Industry veteran with late-stage clinical development, medical affairs, and regulatory experience; well-positioned to advance losmapimod towards a potential regulatory submission […]

The company announced the initiation of RAPIDe-3, the Phase 3 clinical trial evaluating the efficacy and safety of deucrictibant immediate-release […]

MALVERN, Pa., March 18, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused […]

A successful year including NASDAQ listing and positive results from two Phase 3 programs in OCS-01: Phase 3 Stage 1 […]

Tower’s silicon photonics technology to be deployed by Coherent across multiple data rates for high-speed optical transceivers PITTSBURGH, PA, and MIGDAL HAEMEK, [...]

LONDON, March 18, 2024 (GLOBE NEWSWIRE) — WTW (NASDAQ: WTW), a leading global advisory, broking, and solutions company, today announced […]

PERTH, AUSTRALIA, March 18, 2024 (GLOBE NEWSWIRE) — Globavend Holdings Limited (Nasdaq: GVH) (the “Company” or “Globavend”), an emerging e-commerce […]

The unified licence consolidates current licences and provides the groundwork for upcoming technologies Amsterdam and Dhaka, 18 March 2024: VEON Ltd. […]

— Fourth Quarter Revenues of RMB 478.7 million, down 21.8% year over year — Fourth Quarter Net Loss of RMB […]

Stores and JOANN.com Remain Open; Company Continues to Operate as Usual Vendors, Landlords and Other General Unsecured Creditors Are Unimpaired […]